Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · IEX Real-Time Price · USD
4.630
-0.130 (-2.73%)
At close: Jul 19, 2024, 4:00 PM
4.580
-0.050 (-1.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Achieve Life Sciences Market Cap
Achieve Life Sciences has a market cap or net worth of $159.00 million as of July 22, 2024. Its market cap has increased by 80.68% in one year.
Market Cap
159.00M
Enterprise Value
109.80M
1-Year Change
80.68%
Ranking
Category
Stock Price
$4.63
Market Cap Chart
Since December 1, 1998, Achieve Life Sciences's market cap has increased from $67.40M to $159.00M, an increase of 135.91%. That is a compound annual growth rate of 3.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 159.00M | 82.34% |
| Dec 29, 2023 | 87.20M | 266.39% |
| Dec 30, 2022 | 23.80M | -67.62% |
| Dec 31, 2021 | 73.50M | 150.85% |
| Dec 31, 2020 | 29.30M | 565.91% |
| Dec 31, 2019 | 4.40M | -45.68% |
| Dec 31, 2018 | 8.10M | -49.38% |
| Dec 29, 2017 | 16.00M | 6.67% |
| Dec 30, 2016 | 15.00M | -58.45% |
| Dec 31, 2015 | 36.10M | -25.87% |
| Dec 31, 2014 | 48.70M | -60.31% |
| Dec 31, 2013 | 122.70M | -36.19% |
| Dec 31, 2012 | 192.30M | 68.09% |
| Dec 30, 2011 | 114.40M | -29.47% |
| Dec 31, 2010 | 162.20M | 20.59% |
| Dec 31, 2009 | 134.50M | 715.15% |
| Dec 31, 2008 | 16.50M | 1.23% |
| Dec 31, 2007 | 16.30M | -92.75% |
| Dec 29, 2006 | 224.80M | 47.89% |
| Dec 30, 2005 | 152.00M | 101.86% |
| Dec 31, 2004 | 75.30M | -17.34% |
| Dec 31, 2003 | 91.10M | 214.14% |
| Dec 31, 2002 | 29.00M | -68.75% |
| Dec 31, 2001 | 92.80M | 1,500.00% |
| Dec 29, 2000 | 5.80M | -74.22% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 162.94M |
| TriSalus Life Sciences | 162.45M |
| FibroBiologics | 160.74M |
| INmune Bio | 159.84M |
| scPharmaceuticals | 159.36M |
| Context Therapeutics | 159.00M |
| Assertio Holdings | 156.00M |
| Rani Therapeutics Holdings | 155.29M |